The tyrosine kinase inhibitor GNF-7 targets senescent cells through allosteric activation of GCN2
RNA-seq (gene expression) · human · 15 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 15 samples: 5 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE301995_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1288031 and SRA study SRP598837. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 15 samples.
How we read this: 5 replicated groups read from 15 sample titles; they account for 15 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9093924 Cycling cells, DMSO treated, biol rep 1 Cycling cells, DMSO tre…
- GSM9093925 Cycling cells, DMSO treated, biol rep 2 Cycling cells, DMSO tre…
- GSM9093926 Cycling cells, DMSO treated, biol rep 3 Cycling cells, DMSO tre…
- GSM9093927 Senescent cells, DMSO treated, biol rep 1 Senescent cells, DMSO t…
- GSM9093928 Senescent cells, DMSO treated, biol rep 2 Senescent cells, DMSO t…
- GSM9093929 Senescent cells, DMSO treated, biol rep 3 Senescent cells, DMSO t…
- GSM9093930 Senescent cells, GNF7 treated 6 hrs, biol rep 1 Senescent cells, GNF7 t…
- GSM9093931 Senescent cells, GNF7 treated 6 hrs, biol rep 2 Senescent cells, GNF7 t…
- GSM9093932 Senescent cells, GNF7 treated 6 hrs, biol rep 3 Senescent cells, GNF7 t…
- GSM9093933 Senescent cells, DMSO treated 24 hrs, biol rep 1 Senescent cells, DMSO t…
- GSM9093934 Senescent cells, DMSO treated 24 hrs, biol rep 2 Senescent cells, DMSO t…
- GSM9093935 Senescent cells, DMSO treated 24 hrs, biol rep 3 Senescent cells, DMSO t…
- GSM9093936 Senescent cells, GNF7 treated 24 hrs, biol rep 1 Senescent cells, GNF7 t…
- GSM9093937 Senescent cells, GNF7 treated 24 hrs, biol rep 2 Senescent cells, GNF7 t…
- GSM9093938 Senescent cells, GNF7 treated 24 hrs, biol rep 3 Senescent cells, GNF7 t…
- GSE211434 Diverse immune suppressing cancer communications with myeloid cells prevent T cell activation and recruitment and provide resistance to cell cycle inhibitor therapy 81 samples shares activation, inhibitor
- GSE235244 Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma suppress CD8+ T cell activation and inhibit response to immune checkpoint therapy [hPDAC] 8 samples shares activation, senescent
- GSE324062 RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance 61 samples shares activation, inhibitor
- GSE244403 cGAS-STING axis activation drove inflammatory phenotype acquisition of senescent nucleus pulposus cells via p65-mediated transcriptional modulation 12 samples shares activation, senescent
- GSE246354 GCN2 is a determinant of the response to WEE1 kinase inhibition in small-cell lung cancer 18 samples shares gcn2
- GSE274680 Inflammation and lymphocyte activation during longitudinal progression to rheumatoid arthritis in at-risk individuals 243 samples shares activation
- GSE318645 Dual Immune Checkpoint Blockade Induces Distinct Systemic and Intratumoral Immune Activation in Recurrent Glioblastoma 226 samples shares activation
- GSE254732 Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects 215 samples shares activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.